Trials / Unknown
UnknownNCT03320772
TMVP1-ICG Mapping in Laparoscopic SLN Detection in Cervical Cancer
Novel Tumor Targeted Fluorescent TMTP1-ICG Mapping in Laparoscopic Sentinel Lymph Node Detection in Cervical Cancer Patients
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Huazhong University of Science and Technology · Academic / Other
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Sentinel lymph node (SLN) mapping is an acceptable surgical strategy determine whether to perform radical lymphadenectomy in patients with early-stage cervical cancer. Investigators aim to determine the validity of this technique with our novel tumor targeted fluorescent TMVP1-ICG to increased accuracy of SLN mapping.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TMVP1-ICG | Detection of SLN |
| DRUG | ICG | Detection of SLN |
Timeline
- Start date
- 2017-05-01
- Primary completion
- 2018-05-01
- Completion
- 2019-05-01
- First posted
- 2017-10-25
- Last updated
- 2017-10-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03320772. Inclusion in this directory is not an endorsement.